NEWPORT BEACH, CA--(NewMediaWire - May 22, 2017) - ADVANTIS
CORPORATION (OTC PINK: ADVT) filed its first quarter financial report
today. The $119,000 of revenue reported is its highest quarterly
revenue in company history.
Total revenue for the full year of 2016 was $46,337 vs. $119,000
for the first quarter of 2017. Advantis CEO, Christopher Swartz,
has been excelling at developing products and building new partner
and client relationships. "This is not just our highest revenue
quarter ever," Swartz, stated. "This quarterly revenue dwarfs the
annual revenue of any of our previous years. I could not be more
proud of the results our team is achieving." Swartz had been
hinting at a sea change of quarterly numbers for some time, and
first quarter revenue is what Swartz calls 'the beginning.' Last
year Advantis ignited their business plan with some small test runs
of Amstercans, then added the Nugsmasher line of rosin presses,
which promised to significantly increase revenue. "We dealt with
some adversity this year with our rosin press deal, so we decided
to shift gears and make our own press. This adversity was really a
blessing; it set the table for us to continue increasing revenue
quarter over quarter with a higher margin proprietary product."
Swartz says that their rosin press brand is currently being
tested and will be launched shortly. "While I am so proud of the
numbers we report today, there is more work to do. I fully expect
revenue to surge when we introduce it to the market and through our
current product pipeline." Swartz emphasized that the rosin press
is the highest revenue product, but with the volume and growth of
the Amstercans side of the business, he is eager to see how the
escalating revenues of of the two respective product lines will
compare. Swartz is thankful for the patience and faith that
investors have shown in him, and is excited to reward them with the
future revenue that the the press and the growing product lines are
generating. "We have an established client base and product
pipeline, acquire new relationships daily, and continually develop
innovative products. An effective business plan is being executed
upon, and today's quarterly report is the signpost that truly marks
the beginning of our upward trajectory."
Advantis has been steadily growing its client base and product
lineup over the past several months. Amstercans quickly gained
popularity and is proving to be the preferred way to preserve,
present, and package a reliable, quality product that consumers can
trust. Advantis partners with several cultivators, cooperatives,
and dispensaries to package their goods and is able to introduce
other products through the product pipeline that Amstercan creates.
"Service is number one," Swartz said. "At Advantis we work hard to
secure our partners and to create and provide innovative, quality
products. We also recognize the work it takes to maintain those
relationships. It means listening to what our partners want; it
means prompt response to questions and requests; it means providing
products that are in demand, and it ultimately means caring about
the end user and the reputation of our partner and their brands."
Swartz says providing excellent service is the cornerstone of
building lasting business relationships. "Quality, service,
innovation, and trust is what makes Advantis stand apart." Swartz
concluded his comments by saying that he was excited to introduce
more new products in the coming weeks.
Swartz is planning on having another quarterly interview within
the next two weeks to update shareholders on past performance and
future prospects. "I want to make sure that what we are doing is as
transparent as possible, especially as we get ready to become a
fully reporting company," Swartz said. "I'd like to hold this call
to reveal how we have continued to achieve success, and I'll lay
out a rough timeline as to when some of the exciting new
developments and product rollouts should be expected. One exciting
development, for example, is our own Amstervape branded pen got a
packaging and potency makeover; with demand building and a healthy
order pipeline already in place, it will be launched shortly."
Swartz is still awaiting confirmation of the date and time of the
interview.
Links to Advantis websites can be found at advantiscorp.com, rosin6.com, elixicure.com, and amstercan.com
Social Media Facebook Instagram
ABOUT Advantis Corporation
Advantis Corporation (ADVT) focuses on the development of
innovative products that supply the medical, research, and
pharmaceutical industries. The company additionally establishes
domestic and national partnerships with businesses that develop and
sell proprietary pain management, and consumer products and
services. Product lines for consumer health care, music and
entertainment sectors are in development. The company mission is to
find creative, innovative solutions to improve the lives of those
suffering from severe pain, illness, or other debilitating
conditions. To achieve this mission, Advantis Corporation
diversifies its product mix and marketing strategy to further the
acceptance of alternative medicines through various products,
product pipelines and channels of media.
Forward Looking Statements: This news release contains
forward-looking statements made by ADVANTIS CORPORATION. All such
statements included in this press release, other than statements of
historical fact, are forward-looking statements. Although
management believes that the expectations reflected in such
forward-looking statements are reasonable, it can give no assurance
that such expectations will prove to have been correct. Actual
results may differ materially from those indicated by these
statements. The following risk factors, among others, could cause
actual results to differ materially from those described in any
forward- looking statements. These risks and uncertainties include,
but are not limited to, economic conditions, changes in the law or
regulations, demand for products of the Company, the effects of
competition and other factors that could cause actual results to
differ materially fromthose projected or represented in the forward
looking statements. Forward- looking statements are typically
identified by the words: believe, expect, anticipate, intend,
estimate, and similar expressions or which by their nature refer to
future events. The Company is not entitled to rely on the safe
harbor provisions of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934 because it is
not registered under eitherAct.